E-LIB Suche - Ergebnisse für: Candeliere, Antonio

1

Expression of ionotropic glutamate receptor GLUR3 and effec..:

Sarchielli, Paola ; Di Filippo, Massimiliano ; Candeliere, Antonio...
Journal of Neuroimmunology. 188 (2007) 1-2 - p. 146-158 , 2007

Link: https://doi.org/10.1016/..

2

Real‐world experience of ocrelizumab in multiple sclerosis ..:

Fernandez‐Diaz, Eva ; Perez‐Vicente, Jose A. ; Villaverde‐Gonzalez, Ramon...
Annals of Clinical and Translational Neurology. 8 (2020) 2 - p. 385-394 , 2020

Link: https://doi.org/10.1002/..

3

Response to: Comment on "Transorbital ultrasonography for m..:

Candeliere Merlicco, Antonio ; Gabaldón Torres, Laura ; Villaverde González, Ramón...
Acta Neurologica Scandinavica. , 2019

Link: https://doi.org/10.1111/..

4

The Heterogeneity of the Osteoblast Phenotype:

Aubin, Jane E. ; Candeliere, G. Antonio ; Bonnelye, Edith
The Endocrinologist. 9 (1999) 1 - p. 25-31 , 1999

Link: https://doi.org/10.1097/..

5

Ecografía transorbitaria para la medición de la atrofia en ..:

Candeliere, Antonio
http://hdl.handle.net/10952/2797. , 2018

Link: http://hdl.handle.net/10..

6

Assessing illness-related uncertainty in relapsing-remittin..:

Sabin, Julia ; Salas, Elisa ; Martín-Martínez, Jesús...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 10 (2024) 2 - p. , 2024

Link: https://doi.org/10.1177/..

7

Decisional Conflict Regarding Disease-Modifying Treatment C..:

Sabin, Julia ; Salas, Elisa ; Martín-Martínez, Jesús...
Patient Preference and Adherence. 18 (2024) - p. 1163-1171 , 2024

Link: https://doi.org/10.2147/..

8

Illness-related uncertainty and patient experience in relap..:

Sabin, Julia ; Salas, Elisa ; Martín-Martínez, Jesús...
Journal of the Neurological Sciences. 455 (2023) - p. 121863 , 2023

Link: https://doi.org/10.1016/..

9

Therapeutic status quo in patients with relapsing-remitting..:

Saposnik, Gustavo ; Sotoca, Javier ; Sempere, Ángel P....
Multiple Sclerosis and Related Disorders. 45 (2020) - p. 102354 , 2020

Link: https://doi.org/10.1016/..

10

Discontinuation of disease-modifying treatments in multiple..:

Villaverde-González, Ramón ; Candeliere-Merlicco, Antonio ; Alonso-Frías, María Aránzazu...
Multiple Sclerosis and Related Disorders. 46 (2020) - p. 102518 , 2020

Link: https://doi.org/10.1016/..

11

Assessing fatigue in multiple sclerosis: Psychometric prope..:

Meca-Lallana, Virginia ; Brañas-Pampillón, María ; Higueras, Yolanda...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5 (2019) 4 - p. 205521731988798 , 2019

Link: https://doi.org/10.1177/..

12

Prevalence of multiple sclerosis in Health District III, Mu..:

Candeliere-Merlicco, Antonio ; Valero-Delgado, Francisco ; Martínez-Vidal, Salvadora...
Multiple Sclerosis and Related Disorders. 9 (2016) - p. 31-35 , 2016

Link: https://doi.org/10.1016/..

13

Evolución de la esclerosis múltiple tras el embarazo según ..:

Candeliere Merlicco, Antonio
http://hdl.handle.net/11000/4412. , 2017

Link: http://hdl.handle.net/11..

14

Osteoblast Autonomous Pi Regulation via Pit1 Plays a Role i..:

Yoshiko, Yuji ; Candeliere, G. Antonio ; Maeda, Norihiko.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1900051. , 2007

Link: http://www.ncbi.nlm.nih...

15

Real‐world experience of ocrelizumab in multiple sclerosis ..:

Eva Fernandez‐Diaz ; Jose A. Perez‐Vicente ; Ramon Villaverde‐Gonzalez...
https://doi.org/10.1002/acn3.51282. , 2021

Link: https://doi.org/10.1002/..